![Xavier Reveles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xavier Reveles
Directeur des opérations chez
BIOAFFINITY TECHNOLOGIES, INC.
Fortune : 2 335 $ au 31/05/2026
Profil
Mr. Xavier T.
Reveles is a Chief Operating Officer at bioAffinity Technologies, Inc., a Director-Cytogenetics Laboratory at University of Texas Health Science Center At San Antonio and a Member at Association for Molecular Pathology.
Mr. Reveles was previously employed as a Laboratory Director by Oncopath Laboratory.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/01/2025 | 1 398 ( 0,03 % ) | 2 335 $ | 31/05/2026 |
Postes actifs de Xavier Reveles
| Sociétés | Poste | Début |
|---|---|---|
| BIOAFFINITY TECHNOLOGIES, INC. | Directeur des opérations | 01/01/2017 |
Association for Molecular Pathology
 Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Corporate Officer/Principal | - |
University of Texas Health Science Center At San Antonio
 University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Xavier Reveles
| Sociétés | Poste | Fin |
|---|---|---|
Oncopath Laboratory | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Association for Molecular Pathology
Association for Molecular Pathology BiotechnologyHealth Technology Develops molecular diagnostics | Health Technology |
bioAffinity Technologies, Inc.
 bioAffinity Technologies, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostic tests and targeted cancer therapeutics for early-stage cancer diagnostics | Health Technology |
University of Texas Health Science Center At San Antonio
University of Texas Health Science Center At San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopath Laboratory |
Choisissez Zonebourse 
